Hologic Recalls BioZorb Marker Due To Complications With Implanted Devices
Portfolio Pulse from Benzinga Newsdesk
Hologic Inc. has issued a recall for its BioZorb marker due to complications with implanted devices. The recall was announced by the FDA and affects patients who have received the BioZorb marker.
May 22, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Hologic Inc. has recalled its BioZorb marker due to complications with implanted devices. This recall, announced by the FDA, could impact the company's reputation and sales in the short term.
The recall of the BioZorb marker due to complications with implanted devices is likely to negatively impact Hologic's stock price in the short term. The FDA announcement adds regulatory pressure and could affect the company's reputation and sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100